Standout Papers
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer (2016)
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma (2012)
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas (2010)
- Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial (2018)
Immediate Impact
12 by Nobel laureates 10 from Science/Nature 95 standout
Citing Papers
Protein codes promote selective subcellular compartmentalization
2025 StandoutScience
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
2021 Standout
Works of Anas Younes being referenced
Ten‐year follow‐up after intense chemoimmunotherapy with Rituximab‐HyperCVAD alternating with Rituximab‐high dose methotrexate/cytarabine (R‐MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma
2010
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anas Younes | 11335 | 10689 | 4901 | 6399 | 525 | 21.6k | |
| Michael Pfreundschuh | 9849 | 8124 | 3958 | 5661 | 419 | 20.2k | |
| Stephen M. Ansell | 13439 | 14660 | 5515 | 4106 | 732 | 25.9k | |
| Andreas Rosenwald | 10390 | 7491 | 5949 | 5980 | 414 | 19.9k | |
| Andrew D. Zelenetz | 13315 | 8288 | 5739 | 2839 | 369 | 18.6k | |
| Wyndham H. Wilson | 7941 | 8771 | 4700 | 3883 | 324 | 17.2k | |
| Gianluca Gaïdano | 10840 | 9322 | 7588 | 4633 | 610 | 20.0k | |
| Wolfgang Hiddemann | 9636 | 9152 | 6722 | 7956 | 641 | 26.7k | |
| Giorgio Inghirami | 5794 | 7894 | 2930 | 5979 | 262 | 16.5k | |
| Andreas Engert | 11883 | 9034 | 4050 | 2108 | 551 | 20.2k | |
| Bruce D. Cheson | 16587 | 10432 | 10596 | 4898 | 353 | 29.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...